Clinical Trial Update: A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating RSC-1255 in patients with advanced malignancies carrying RAS mutations, sponsored by RasCal Therapeutics, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Glioblastoma
• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• RSC-1255

Snippet

Sponsor: RasCal Therapeutics, Inc. | Conditions: Advanced Malignant Solid Neoplasm, RAS Mutation | Phase 1 | Status: RECRUITING